Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D

Plasmablastic B-cell malignancies include plasmablastic lymphoma and subsets of multiple myeloma and diffuse large B-cell lymphomaDLBCL. These diseases can be difficult to diagnose and treat, and they lack well-characterized cell line models. Here, immunophenotyping and FOXP1 expression profiling id...

Descripción completa

Detalles Bibliográficos
Autores principales: Gascoyne, Duncan M., Lyne, Linden, Spearman, Hayley, Buffa, Francesca M., Soilleux, Elizabeth J., Banham, Alison H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460784/
https://www.ncbi.nlm.nih.gov/pubmed/28001444
http://dx.doi.org/10.1210/en.2016-1802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460784/
https://www.ncbi.nlm.nih.gov/pubmed/28001444
http://dx.doi.org/10.1210/en.2016-1802

Ejemplares similares